Awais Farid
Overview
Explore the profile of Awais Farid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
From Fundamentals to Synthesis: Covalent Organic Frameworks as Promising Materials for CO Adsorption
Aslam A, Amjad S, Irshad A, Kokab O, Ullah M, Farid A, et al.
Top Curr Chem (Cham)
. 2025 Feb;
383(1):10.
PMID: 39987291
Covalent organic frameworks (COFs) are highly crystalline polymers that possess exceptional porosity and surface area, making them a subject of significant research interest. COF materials are synthesized by chemically linking...
2.
Arshed M, Umer M, Kiran M, Akhter A, Gillani A, Qamer S, et al.
Sci Rep
. 2024 Sep;
14(1):20613.
PMID: 39232055
Hyperlipidemia significantly contributes to the risk of developing cardiovascular diseases. However, about half of the patients do not adhere to their antihyperlipidemic medications, leading to healthcare costs and premature mortality....
3.
Ashraf Baig M, Ma J, Gao X, Khan M, Ali A, Farid A, et al.
Int J Biol Macromol
. 2023 Mar;
236:123988.
PMID: 36907299
This study aimed to develop a robust approach for the early diagnosis and treatment of tumors. Short circular DNA nanotechnology synthesized a stiff and compact DNA nanotubes (DNA-NTs) framework. TW-37,...
4.
Khan M, Amin A, Farid A, Ullah A, Waris A, Shinwari K, et al.
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678781
Infectious diseases continue to be a leading cause of morbidity and mortality worldwide. The majority of infectious diseases are caused by intracellular pathogenic bacteria (IPB). Historically, conventional vaccination drives have...
5.
Malik Z, Umer M, Nabeel Ali K, Kawish A, Arshed M, Zofeen S, et al.
Diseases
. 2022 Nov;
10(4).
PMID: 36412597
Background: Functional gastrointestinal diseases (FGIDs) are an important yet highly under explored area among public health issues. FGIDs' complex etiology makes them of interest along with their prevalence in children...
6.
Ashraf Baig M, Fatima A, Gao X, Farid A, Khan M, Zia A, et al.
J Control Release
. 2022 Oct;
352:98-120.
PMID: 36243235
In this study, novel multilayered magnetic nanoparticles (ML-MNPs) loaded with DNase and/or vancomycin (Vanc) were fabricated for eliminating multispecies biofilms. Iron-oxide MNPs (IO-core) (500-800 nm) were synthesized via co-precipitation; further,...
7.
Sarfraz M, Ivascu L, Shah S, Farid A
Front Psychol
. 2022 Aug;
13:970631.
PMID: 35992479
No abstract available.
8.
Ashraf Baig M, Gao X, Khan M, Farid A, Zia A, Wu H
Int J Biol Macromol
. 2022 Aug;
220:520-527.
PMID: 35988727
Nanoscale double-crossovers (DX), antiparallel (A), and even half-turns-perimeter (E) DNA tiles (DAE-tiles) with rectangular shapes can be packed into large arrays of micrometer-scale lattices. But the features and mechanical strength...
9.
Hosnedlova B, Kabanov D, Kepinska M, Narayanan V, Parikesit A, Fernandez C, et al.
Nanomaterials (Basel)
. 2022 Jul;
12(13).
PMID: 35808019
One approach for solving the problem of antibiotic resistance and bacterial persistence in biofilms is treatment with metals, including silver in the form of silver nanoparticles (AgNPs). Green synthesis is...
10.
Krishnan P, Banas D, Durai R, Kabanov D, Hosnedlova B, Kepinska M, et al.
Pharmaceutics
. 2020 Sep;
12(9).
PMID: 32872234
Silver nanoparticles (AgNPs) have recently become very attractive for the scientific community due to their broad spectrum of applications in the biomedical field. The main advantages of AgNPs include a...